Chyung Yung H. Insider Trades

Insider Trading History

Track insider trading activity for Chyung Yung H.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
Chief Medical Officer
Holding Value $474k 44,000 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 44,000 shares
$10.56
$10.77
Keros Therapeutics
Keros Therapeutics KROS
Chief Medical Officer
Holding Value $1.18M 110,000 shares
Last Trade
Nov 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.47M 110,000 shares
$67.91
$10.77
Talaris Therapeutics
Talaris Therapeutics TALS
Chief Medical Officer
Holding Value $199k 73,211 shares
Last Trade
Oct 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199k 73,211 shares
$2.72
$2.72
Tourmaline Bio
Tourmaline Bio TRML
Chief Medical Officer
Holding Value $3.51M 73,211 shares
Last Trade
Oct 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$693k 73,211 shares
$9.46
$47.98
Tourmaline Bio
Tourmaline Bio TRML
Chief Medical Officer
Holding Value $6.92M 144,215 shares
Last Trade
Oct 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.95M 144,215 shares
$27.40
$47.98
Talaris Therapeutics
Talaris Therapeutics TALS
Chief Medical Officer
Holding Value $392k 144,215 shares
Last Trade
Oct 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$392k 144,215 shares
$2.72
$2.72
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $11.7M 258,496 shares
Last Trade
Feb 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$678k 37,500 shares
$18.08
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $1.7M 37,500 shares
Last Trade
Feb 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$678k 37,500 shares
$18.08
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $10M 220,996 shares
Last Trade
Jan 18, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27.7k 1,421 shares
$19.46
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $10.2M 225,534 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.09M 52,500 shares
$58.93
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $714k 15,750 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$928k 15,750 shares
$58.93
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $3.4M 75,000 shares
Last Trade
Feb 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 75,000 shares
$13.52
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $2.54M 56,000 shares
Last Trade
Jan 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$846k 56,000 shares
$15.11
$45.33
Scholar Rock Holding
Scholar Rock Holding SRRK
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
May 23, 2018 Sale
No data
No data
$45.33

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up